NVP-BGJ398 ≥99% (by HPLC)
Supplier: Enzo Life Sciences
Synonyms:
3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-methylurea, 3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea, Infigratinib
CHM225-0010
CHM225-0025
CHM225-0050
CHM225-0100
CHM225-0200
CHM225-0500
CHM225-1000
76203-224EA
171.13
USD
76203-224
76203-226
76203-228
76203-230
76203-232
76203-234
76203-236
NVP-BGJ398 ≥99% (by HPLC)
NVP-BGJ398
Infigratinib is a pan FGFR kinase inhibitor, and is an orally bioavailable pan inhibitor of human fibroblast growth factor receptors (FGFRs) with potential antiangiogenic and antineoplastic activities.
- FGFR kinase inhibitor
- White solid
- Soluble in DMSO.
Formula:
C₂₆H₃₁Cl₂N₇O₃ MW: 560.5 g/mol Storage Temperature: Freezer |
MDL Number:
MFCD22123241 CAS Number: 872511-34-7 |
Learn more
About VWR
Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...